Clin Cancer Res: DNA methyl transferase inhibitor Guadecitabine combined with cisplatin and giscitabine to treat solid malignancies
JCO: The treatment of rhonamide combined with R-CHOP can prolong the survival of patients with untreated diffuse large B-cell lymphoma
ASCO GU 2021: The efficacy of the combined treatment of metastatic renal cell carcinoma with Navuliyu monoanti- and Ipi-anti-anti-drugs
Clin Cancer Res: Pym single-drug treatment PD-L1 combined positive score≥10 efficacy of gastric/gastroesophageal junction cancer
JAMA Neurol: Pernisson Shock Therapy combined with a rapid reduction program to treat moderate to severe muscle weakness
research progress in food safety testing based on cellulose-based multi-functional substrate combined with SERS intelligent sensing
Somaglutide combined with cilofexo/firsocostat treatment NASH II with positive results
AZ's Breztri scored in the COPD trial, adding a place to GSK's triple-combined battle
JCO: Chemotherapy combined with primary tumor removal does not improve the efficacy of patients with advanced colorectal cancer
Xinda Bio and Sanoki have reached a clinical partnership to develop Xindili monoantigen combination therapy
The disease control rate of 90% mRNA cancer vaccine/Keytruda combination had positive early clinical results
ASCO GU 2021: Nivolumab combined with Cabozantinib and Schoinidinib in late-stage renal cell carcinoma (CheckMate 9ER study)
J Clin Oncol: Eprenetapopt combined with Aza cytosine to treat TP53 mutant MDS and AML
The study found four major combinations that increased the risk of death in new crown patients
with the new auxiliary drug Narvon anti-monodrive therapy or combined Ipi monotherapy
Toripalimab is a combination of chemotherapy to treat nasopharyngeal cancer, and China's State Drug
An Approach Combining Rapid cDNA Amplification and Chemical Synthesis for the Identification of Novel, Cathelicidin-Derived, Antimicrobial Peptides
Pomegranate extract and chrysanthemum sugar may be a high-quality cholesterol-lowering combination
Cargies launches a new sweetener that combines stevia, honey and sugar.
Fda approves Piqray pills in combination with fullvestrant therapy